En Es
Categories

EUROIMMUN AG

Produces reagents for medical laboratory diagnostics, including test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies
Gold member
Products Covid-19Summary
Close

Covid-19 EUROIMMUN AG

Clinical Laboratory

COVID-19 PCR and ELISAs
COVID-19 PCR and ELISAs

EUROIMMUN’s portfolio for COVID-19 diagnostics includes the EURORealTime SARS-CoV-2 for sensitive direct virus detection, as well as ELISAs based on spike protein domain S1 (IgG, IgA) or modified nucleocapsid protein (NCP, IgG). The IgG ELISAs demonstrate specificities of 99.6% and 99.8% and sensitivities of 94.4% and 94.6%, respectively. The antibody detection can also be performed using dried blood spots taken with the Blood Collection Set. The ELISAs can be processed fully automatically, for example on the EUROLabWorkstation ELISA. All the tests are CE marked.
More details
Close

About EUROIMMUN AG

Number of Employees: 1000+
Year of Establishment: 1987
Produces reagents for medical laboratory diagnostics, including test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies
FaceBook Twitter Google+ Linked in
ELISA Test

ELISA Test

Model: Aspergillus Antigen ELISA
Request Information

Description:

The Aspergillus Antigen ELISA provides quantitative in vitro determination of Aspergillus spp. to support the diagnosis of invasive aspergillosis. The test is based on a monoclonal antibody for the detection of Aspergillus-specific galactomannoprotein, which is produced during active fungal growth.
Read More

Full Description

Description

The Aspergillus Antigen ELISA provides quantitative in vitro determination of Aspergillus spp. to support the diagnosis of invasive aspergillosis. The test is based on a monoclonal antibody for the detection of Aspergillus-specific galactomannoprotein, which is produced during active fungal growth. The procedure is performed on patient serum or bronchoalveolar lavage fluid and can be semi-automated. In a published study the test yielded comparable sensitivity and specificity to another commercially available ELISA (J. Clin. Microbiol, Apr 2019). Request Information

Send A Message To This Supplier

* Required Information
* Email
To
EUROIMMUN AG (ELISA Test)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions